 | Up a level |
Landi, Antonio; Aboyans, Victor; Angiolillo, Dominick J; Atar, Dan; Capodanno, Davide; Fox, Keith A A; Halvorsen, Sigrun; James, Stefan; Jüni, Peter; Leonardi, Sergio; Mehran, Roxana; Montalescot, Gilles; Navarese, Eliano Pio; Niebauer, Josef; Oliva, Angelo; Piccolo, Raffaele; Price, Susanna; Storey, Robert F; Völler, Heinz; Vranckx, Pascal; ... (2024). Antithrombotic Therapy in Patients with Acute Coronary Syndrome: Similarities and Differences between a European Expert Consensus Document and the 2023 European Society of Cardiology Guidelines. European heart journal. Acute cardiovascular care, 13(1), pp. 173-180. Oxford University Press 10.1093/ehjacc/zuad158
Valgimigli, Marco; Aboyans, Victor; Angiolillo, Dominick; Atar, Dan; Capodanno, Davide; Halvorsen, Sigrun; James, Stefan; Jüni, Peter; Kunadian, Vijay; Landi, Antonio; Leonardi, Sergio; Mehran, Roxana; Montalescot, Gilles; Navarese, Eliano Pio; Niebauer, Josef; Oliva, Angelo; Piccolo, Raffaele; Price, Susanna; Storey, Robert F; Völler, Heinz; ... (2023). Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease: 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Association for Acute CardioVascular Care (ACVC) and European Association of Preventive Cardiology (EAPC). European heart journal. Cardiovascular pharmacotherapy, 9(5), pp. 462-496. Oxford University Press 10.1093/ehjcvp/pvad032
Navarese, Eliano Pio; Landi, Antonio; Oliva, Angelo; Piccolo, Raffaele; Aboyans, Victor; Angiolillo, Dominick; Atar, Dan; Capodanno, Davide; Fox, Keith A A; Halvorsen, Sigrun; James, Stefan; Jüni, Peter; Kunadian, Vijay; Leonardi, Sergio; Mehran, Roxana; Montalescot, Gilles; Niebauer, Josef; Price, Susanna; Storey, Robert F; Völler, Heinz; ... (2023). Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease. Two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC) and European Association of Preventive Cardiology (EAPC). European heart journal. Cardiovascular pharmacotherapy, 9(3), pp. 271-290. Oxford University Press 10.1093/ehjcvp/pvad016
Wenzl, Florian A; Kraler, Simon; Ambler, Gareth; Weston, Clive; Herzog, Sereina A; Räber, Lorenz; Muller, Olivier; Camici, Giovanni G; Roffi, Marco; Rickli, Hans; Fox, Keith A A; de Belder, Mark; Radovanovic, Dragana; Deanfield, John; Lüscher, Thomas F (2022). Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation. The lancet, 400(10354), pp. 744-756. Elsevier 10.1016/S0140-6736(22)01483-0
Piccini, Jonathan P; Caso, Valeria; Connolly, Stuart J; Fox, Keith A A; Oldgren, Jonas; Jones, W Schuyler; Gorog, Diana A; Durdil, Václav; Viethen, Thomas; Neumann, Christoph; Mundl, Hardi; Patel, Manesh R (2022). Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study. The lancet, 399(10333), pp. 1383-1390. Elsevier 10.1016/S0140-6736(22)00456-1
